Vonoprazan Fumarate is the fumarate salt form of vonoprazan, a pyrrole derivative and reversible potassium-competitive acid blocker (P-CAB). It inhibits gastric acid secretion by competitively binding to the potassium ion binding site of the gastric H+/K+ ATPase proton pump.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2098974-13-9
Vonoprazan
active pharmaceutical ingredient
Vonoprazan Fumarate
active pharmaceutical ingredient
Vonoprazan Fumarate
potassium-competitive acid blocker
5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanol
Pharmaceutical intermediate
5-(2-Fluorophenyl)-N,N-dimethyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine
n.a
Tegoprazan
potassium-competitive acid blocker
Revaprazan Hydrochloride
potassium-competitive acid blocker
Abeprazan
potassium-competitive acid blocker
(E)-but-2-enedioic acid;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine
ROGSHYHKHPCCJW-WLHGVMLRSA-N
CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=C/C(=O)O)\C(=O)O